Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 2:23 AM
Study NCT ID:
NCT07361003
Status:
RECRUITING
Last Update Posted:
2026-01-22
First Post:
2025-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-30
First Submit QC Date:
None
Study First Post Date:
2026-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-14
Last Update Post Date:
2026-01-22
Last Update Post Date Type:
ACTUAL